Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Cho

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 28, 2018
The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancerHong Jae Chon, Chan Kim, Arthur Cho, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 4, 2015
Prognostic impact of cytological fluid tumor markers in non-small cell lung cancerArthur Cho, Jin Hur, Yoo Jin Hong, et al.
Annals of Nuclear Medicine|February 4, 2016
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinomaSun Min Lim, Hyunki Kim, Beodeul Kang, et al.
Experimental & Molecular Medicine|August 6, 2025
Novel mechanism whereby metformin improves glucose homeostasis: TXNIP-GLUT1 axis modulation enhances intestinal glucotonic effectsChan Woo Kang, Jung Ho Nam, Ju Hun Oh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicalsNing Li, Jawed Alam, M Indira Venkatesan, et al.
Scientific Reports|May 26, 2021
Splenic uptake on FDG PET/CT correlates with Kikuchi-Fujimoto disease severityHye Seong, Yong Hyu Jeong, Woon Ji Lee, et al.
Therapeutic Advances in Medical Oncology|January 17, 2022
Predicting treatment outcomes using <sup>18</sup>F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapyChang Gon Kim, Sang Hyun Hwang, Kyung Hwan Kim, et al.
Thoracic Cancer|November 8, 2022
Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in KoreaWongi Woo, Young Ho Yang, Yoon Jin Cha, et al.
BMC Cancer|March 17, 2016
Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancerArthur Cho, Jin Hur, Yong Wha Moon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2021
STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [<sup>18</sup>F]FLT PET imagingKeke Liang, Evan R Abt, Thuc M Le, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 28, 2018
The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancerHong Jae Chon, Chan Kim, Arthur Cho, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 4, 2015
Prognostic impact of cytological fluid tumor markers in non-small cell lung cancerArthur Cho, Jin Hur, Yoo Jin Hong, et al.
Annals of Nuclear Medicine|February 4, 2016
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinomaSun Min Lim, Hyunki Kim, Beodeul Kang, et al.
Experimental & Molecular Medicine|August 6, 2025
Novel mechanism whereby metformin improves glucose homeostasis: TXNIP-GLUT1 axis modulation enhances intestinal glucotonic effectsChan Woo Kang, Jung Ho Nam, Ju Hun Oh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicalsNing Li, Jawed Alam, M Indira Venkatesan, et al.
Scientific Reports|May 26, 2021
Splenic uptake on FDG PET/CT correlates with Kikuchi-Fujimoto disease severityHye Seong, Yong Hyu Jeong, Woon Ji Lee, et al.
Therapeutic Advances in Medical Oncology|January 17, 2022
Predicting treatment outcomes using <sup>18</sup>F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapyChang Gon Kim, Sang Hyun Hwang, Kyung Hwan Kim, et al.
Thoracic Cancer|November 8, 2022
Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in KoreaWongi Woo, Young Ho Yang, Yoon Jin Cha, et al.
BMC Cancer|March 17, 2016
Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancerArthur Cho, Jin Hur, Yong Wha Moon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2021
STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [<sup>18</sup>F]FLT PET imagingKeke Liang, Evan R Abt, Thuc M Le, et al.
Pageof 9